In the second episode of NCIA’s new multi-part #IndustryEssentials webinar series, titled “Advancing Cannabis Science: Research Opportunities and Safety Post-Rescheduling,” we delved into the significant changes and opportunities that would emerge following the rescheduling of cannabis to a Schedule III drug. Led by NCIA’s Scientific Advisory Committee, this session provided a comprehensive overview of the … Continue reading Cannabis Rescheduling Impact on Research and Safety: Insights from NCIA Webinar